GHRS
GH Research PLC
NASDAQ: GHRS · HEALTHCARE · BIOTECHNOLOGY
$20.53
+7.15% today
Updated 2026-04-30
Market cap
$1.26B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.79
Dividend yield
—
52W range
$9 – $25
Volume
0.2M
GH Research PLC (GHRS) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
8 of 8
Last 8 quarters
Avg EPS surprise
+24.1%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
-29.4%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-3.2%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-5.7%
2026-02-26
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-26 | $-0.22 | +17.8% | $15.75 | $14.85 | -5.7% |
| 2025-11-06 | $-0.23 | +4.2% | $13.59 | $13.50 | -0.7% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.27 | $-0.22 | +17.8% | — | — |
| 2025-09-30 | $-0.24 | $-0.23 | +4.2% | — | — |
| 2025-06-30 | $-0.21 | $-0.15 | +28.6% | — | — |
| 2025-03-31 | $-0.35 | $-0.19 | +45.7% | — | — |
| 2024-12-31 | $-0.22 | $-0.17 | +23.3% | — | — |
| 2024-09-30 | $-0.24 | $-0.23 | +4.2% | — | — |
| 2024-06-30 | $-0.22 | $-0.20 | +9.1% | — | — |
| 2024-03-31 | $-0.22 | $-0.15 | +31.8% | $80000.00 | — |
| 2023-12-31 | $-0.20 | $-0.21 | -5.0% | — | — |
| 2023-09-30 | $-0.20 | $-0.11 | +45.0% | — | — |
| 2023-06-30 | $-0.25 | $-0.15 | +40.0% | — | — |
| 2023-03-31 | $-0.22 | $-0.21 | +4.5% | — | — |
Frequently asked questions
Has GH Research PLC beaten earnings estimates?
GH Research PLC has beaten Wall Street EPS estimates in 8 of its last 8 quarterly reports, with an average EPS surprise of +24.1% over the last 4 quarters.
How does GHRS stock react to earnings?
GHRS stock has moved an average of -3.2% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.